Literature DB >> 1663806

Skip lesions in the axilla in breast cancer, and their association with micrometastases.

C A Msuya1, F Hartveit.   

Abstract

The term 'skip lesion', referring to a tumour-bearing node in the axilla in breast cancer, presupposes that nodal colonization usually occurs in sequence with the path of the lymph flow. Skip lesions are thus out of step with the system. The present study of axillary nodes from 73 node-positive patients demonstrates that skip lesions have much in common with lone micrometastases found at any level, and are thus but a variant of the pattern found in early colonization of the axilla. This in turn indicates that in contrast to a progressive build up of tumour growth first at the lower and later at the middle level, early colonization may be a random process. This again stresses the importance of nodal dissection versus biopsy in the management of breast cancer, particularly in view of recent reports on the prognostic significance of micrometastases.

Entities:  

Mesh:

Year:  1991        PMID: 1663806     DOI: 10.1007/bf01961164

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

Review 1.  Are breast cancer axillary node micrometastases worth detecting?

Authors:  A M Neville
Journal:  J Pathol       Date:  1990-08       Impact factor: 7.996

2.  Standardized axillary dissection: specimen weight and nodal content in breast cancer.

Authors:  F Hartveit
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Obscure axillary lymph-node metastasis in carcinoma of the breast.

Authors:  O SAPHIR; G D AMROMIN
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

4.  Significance of occult metastases. A study of breast cancer.

Authors:  J W PICKREN
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

5.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases.

Authors:  E R Fisher; A Palekar; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

6.  Significance of axillary macrometastases and micrometastases in mammary cancer.

Authors:  A G Huvos; R V Hutter; J W Berg
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

7.  The axillary nodes and tumor size in breast cancer.

Authors:  F Hartveit; M Tangen; J F Halvorsen
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

8.  Axillary micrometastasis and macrometastasis in carcinoma of the breast.

Authors:  F F Attiyeh; M Jensen; A G Huvos; A Fracchia
Journal:  Surg Gynecol Obstet       Date:  1977-06

9.  Time-dependent changes in the axillary nodes in breast cancer: nodal area.

Authors:  F Hartveit; M Tangen; J F Halvorsen; G Samsonsen
Journal:  Oncology       Date:  1985       Impact factor: 2.935

10.  Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A A Fracchia; D W Kinne
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

View more
  4 in total

1.  Clinical significance of skip metastasis in patients with gastric cancer.

Authors:  Hiroaki Saito; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

2.  Reassessment of tumour-load in the axilla in patients with breast cancer: a preliminary report.

Authors:  F Hartveit; C A Msuya
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

3.  The orderly progression of melanoma nodal metastases.

Authors:  D Reintgen; C W Cruse; K Wells; C Berman; N Fenske; F Glass; K Schroer; R Heller; M Ross; G Lyman
Journal:  Ann Surg       Date:  1994-12       Impact factor: 12.969

4.  Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression.

Authors:  Huan Wang; Xiao-Yun Mao; Ting-Ting Zhao; Xin-Yu Zheng; Feng Jin; Ji-Guang Li
Journal:  Tumour Biol       Date:  2012-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.